병기 Ⅰ, Ⅱ 자궁 경부암에서 방사선치료 후 생존율 및 합병증 분석

마선영(Sun Young Ma),조흥래(Heung Lae cho),손승창(Seung Chang Sohn) 대한방사선종양학회 1995 Radiation Oncology Journal Vol.13 No.4

목적 : 수술을 시행 받지 않은 ⅠB, ⅡA, ⅡB 자궁경부암 환자에서 외부 방사선 조사 및 강내조사 방법에 따른 생존율과 방광 및 직장 합병증 발생률을 분석하여 보고자 하였다. 방법 : 1984년 11월 부터 1993년 12월 까지 인제대학교 부산백병원 치료방사선과에서 근치적 방사선치료 또는 화학요법을 병행한 자궁경부암 병기 ⅠB, ⅡA, ⅡB 환자 127명 중 추적 가능하였던 환자 107명을 대상으로 생존율을 후향적 분석하였고, 합병증은 91명에서 추적 가능하였다. 방사선 단독으로 치료 받은 환자가 86명, 보조적 화학요법을 받은 환자는 21명이었다. 대상 환자들의 추적 조사 기간은 3개월에서 118개월이었고 9중앙값, 47개월), 환자의 연령은 31세에서 76세까지 (중앙값, 56세) 분포를 보였다. FIGO 병기 ⅠB기가 26명, ⅡA기가 40명, ⅡB기가 41명 이었다. 강내 방사선 조사는 저선량률 강내조사를 받은 군(80명)과 고선량률 강내조사를 받은 군 (21명)으로 나누어 분석하였다. 저선량률 강내조사는 1회 시행받은 환자군(63명)과 2회로 나누어 시행받은 환자군(17명)을 비교하여 보았고, 저선량률 강내조사를 받은 환자 중에서 전골반 외부 조사선량에 따라 4500cGy 이하인 환자군(18명)과 4501cGy 이상인 환자군(62명)으로 나누어 분석하였다. 외부 조사선량이 5000cGy 이상인 환자 중에서 중심선 차폐(midline block)를 한 군(36명)고 하지 않은 군(31명)을 나누어 분석하였다. 결과 : 전에 환자의 5년생존율은 69%였고, 병기별 5년생존율은 ⅠB 92%, ⅡA 75%, ⅡB 53%로 나왔다. 직장 합병증은 Grade 1이 20명(22%), Grade 2가 22명(24%)이었고, 방광 합병증은 Grade 1이 22명(24%), Grade 2가 17명(19%) 이었으며 수술을 요할 정도의 심각한 합병증은 없었다. 방광 및 직장 합병증이 나타났던 군에서 합병증이 없었던 군보다 방광 및 직장에 조사 된 최대 방사선량(maximum dose)의 평균치가 높았던 것으로 나타났다 (최대 방광 조사선량 평균 : 7680cGy v 6960cGy (p<0.01), 최대 직장 조사선량 평균 : 7041cGy v 6269cGy (p<0.01)). 외부 조사선량이 4500cGy 이하인 군과 4501cGy 이상인 군에서 생존율과 방광 합병증 발생율은 통계적 차이가 없었으나 Grade 2 직장 합병증 발생율은 각각 6.3%, 25.5% (p<0.05)로 4500cGy 이하인 군에서 낮은 것으로 나타났다. 고선량률 강내조사를 받은 군과 저선량률 강내조사를 받은 군 사이에 생존율은 병기별 분석에서 유의한 차이가 없었으며, 합병증 발생률은 고선량률 강내조사 군에서 더 높게 나타났지만 Point A와 직장에 조사된 방사선량이 저선량률 강내조사 군에 비해 높아 고선량률 강내치료 자체가 합병증 발생률을 높인 인자로 볼 수는 없었다. (p<0.01). 저선량률 강내조사의 횟수에 따른 생존율이나 합병증 발생률의 차이는 없었다. 외부조사시 중심선 차폐 여부에 따른 생존율과 직장 합병증 발생률의 유의한 차이는 없었으나 방광 합병증 발생률은 중심선 차폐를 시행한 군에서 더 높았다 (p<0.05). 결론: 병기 ⅠB, ⅡA, ⅡB 자궁경부암에서 방사선 치료방법에 따른 생존율은 통계적으로 유의한 차이가 없었으며, 직장 합병증은 외부 조사선량이 4500cGy이하인 군에서 4501cGy 이상인 군에서보다 낮은 것으로 나타났고, 최대 방광 선량과 최대 직장 선량이 합병증 발생률과 유의한 상관관계를 보여, 향후 전골반 외부 조사선량이 4500cGy를 넘지 않도록 주의하여야 되겠고, 강내 치료 계획시 직장 및 방광 선량을 가능한 낮추도록 치료 선량을 결정해야 할 것이다. Purpose : To analyze survival rate and late rectal and bladder complication for patients with stage Ⅰ and Ⅱ carcinoma of uterine cervix treated by radiation alone or combined with chemotherapy Materials and Methods : Between November 1984 and December 1993. 127 patients with stage Ⅰ and Ⅱ carcinoma of uterine cervix treated by radiation alone or combined therapy of radiation and chemotherapy. Retrospective analysis for survival rate was carried out on eligible 107 patients and review for complication was possible in 91 patients. The median follow-up was 47 months (range 3-118) and the median age of patiens was 56 years (range 31-76). 26 patients were stage ⅠB by FIGO classification. 40 were stage ⅡA and 41 were stage ⅡB. 86 cases were treated by radiation alone and 21 were treated by radiation and chemotherapy. 101 patients were treated with intracavitary radiation therapy (ICRT). of these. 80 were received low dose rate (LDR) ICRT and 21 were received high dose rate (HDR) ICRT. Of the patients who received LDR ICRT. 63 were treated by 1 intracavitary insertion and 17 were underwent 2 insertion. And we evaluated the external radiation dose and midline shield. Results : Actuarial survival rate at 5 years was 92% for stage ⅠB. 75% for stage ⅡA. 53% for stage ⅡB and 69% in all patients. Grade 1 rectal complications were developed in 20 cases (22%). grade 2 were in 22 cases (24%). 22 cases (24%) of grade 1 urinary complications and 17 cases (19%) of grade 2 urinary complications were observed. But no patient had severe complications that needed surgical management or admission care. Maximum bladder dose for the group of patients with urinary complications (7608 cGy v 6960cGy. p<0.01). Maximum rectal dose for the group of patients with rectal complications was higher than that for the patients without rectal complications (7041cGy v 6269cGy p<0.01). While there was no significant difference for survival rate or bladder complication incidence as a function of dose to whole pelvis. Grade 2 rectal complication incidence was significantly lower for the patients receiving less than 4500cGy (6.3% v 25.5%. p<0.05). There was no significant differance between HDR ICRT group and LDR ICRT group for survival rate according to stage. on the other hand complication incidence was higher in the HDR group than LDR group. This was maybe due to different prescription doses between HDR group and LDR group. Midline shield neither improved survival rate nor decreased complication rate. The number of insertion in LDR ICRT group did not affect on survival and compication rate. Conclusion : In stage Ⅰ and Ⅱ carcinoma of uterine cervix. there was no significant differance for 5 year survival rate by radiation therapy technique. Rectal complication incidence was as a function of dose to whole pelvis and there were positive correlations of maximum dose of rectum and bladder and each complication incidence. So we recommand whole pelvis dose less than 4500cGy and maximum dose of rectum and bladder ad low as possible.

재가노인 방문요양보호사의 낙상관련 대처 경험에 관한 연구

임선영 ( Sun-young Lim ),박혜선 ( Hye-sun Park ),마예원 ( Ryewon Ma ) 대한통합의학회 2021 대한통합의학회지 Vol.9 No.3

Purpose: The purpose of this study was to understand the experience and meaning of falls among care workers caring for the elderly. Methods: The participants comprised 10 care workers in Seoul and Gyeonggi Province, South Korea. The data collection period was from September to November 2020, and the data were obtained through individual in-depth interviews. The collected data were analyzed using the content analysis method of qualitative research. The main interview questions were as follows: First, in the event of a fall, “can you tell us about your experience and how you dealt with the fall?; second, “can you tell us about your role and the role of family members or the center that manages falls that occur outside of nursing visits.”, third, “can you tell us about the difficulties in managing falls based on your experience?”, and fourth, “how are falls that occur during nursing visits managed?” Results: As a result of analyzing the experiences of nursing care workers of falls while caring for elders in their homes, five main themes were derived. These were understanding the characteristics of the elderly at home, understanding possible emergency situations, providing caring services, minimizing physical harm, and delivering clear information. Conclusion: A significant finding of this study was that care workers who visit and provide care to elders at home confirmed the need for standard guidelines on appropriate responses in the event of a fall at home and the importance of managing emergencies arising from falls among elders at home. These results highlight the need for the development of emergency response education programs, such as programs on fall care among nurses and care workers who provide care to the elderly, and for enhanced understanding of the fall risk of elders who live at home.

감마지표 분석을 통한 호흡연동방사선치료의 정량적 평가

마선영,최지훈,정태식,임상욱,Ma, Sun Young,Choi, Ji Hoon,Jeung, Tae Sig,Lim, Sangwook 한국의학물리학회 2013 의학물리 Vol.24 No.3

일반적으로 호흡연동방사선치료(gated radiation therapy)의 평가를 위해 호흡에 의한 장기의 움직임을 모사하는 움직이는 팬텀(moving phantom)을 사용한다. 표적(target)은 모든 방향으로 움직이기 때문에 모든 방향의 움직임을 고려하여야 한다. 본 연구에서는 감마지표(gamma index) 분석을 통한 호흡연동방사선치료의 평가방법을 제시하고 움직임영역(motion range)에 따른 적절한 연동창(gating window)의 크기를 알아보고자 한다. 두미축(craniocaudal) 방향으로 움직임을 모사하는 팬텀을 제작하였다. 이 팬텀은 움직이는 받침대(moving platform), 2차원 이온전리함배열(I'm MatriXX, IBA Dosimetry, Germany), 및 고체물팬텀(solid water phantom)으로 이루어졌다. 6 MV 에너지의 광자선을 $4{\times}4cm^2$의 조사면(field size)으로 호흡연동방사선치료 시스템을 이용하여 팬텀을 각각 1, 2, 3, 4, 및 5 cm 만큼 움직이도록 하고 방사선을 조사하였다. 연동창은 각각 40~60%, 30~70%, 및 0~90%으로 설정하였다. 2차원 이온전리함배열은 각 시나리오에 따라 선량분포를 획득하였고 $4{\times}4cm^2$ 조사면으로 정지한 상태에서 조사한 선량분포와 비교하였다. 허용범위를 3%/3 mm로 설정하고 감마지표를 계산하였다. 연동창(gating window)의 크기가 클수록 합격률(pass rate)는 낮아졌고, 운동영역(motion range)이 커질수록 합격률은 낮아졌다. 호흡연동방사선치료를 시행하지 않고 운동영역이 2 cm의 병소를 치료할 경우 합격률은 96% 이하로 현저히 떨어졌다. 그러나 호흡연동방사선치료를 시행하면 합격률은 99% 이상으로 올릴 수 있었다. 운동영역이 4 cm 이상일 경우 호흡연동방사선치료를 하더라도 연동창을 30~70%로 선택할 경우 합격률이 97%를 넘지 못하였다. 그러나 연동창을 40~60%를 선택할 경우 합격률은 99% 이상이었다. Generally, to evaluate gated radiation therapy, moving phantoms are used to simulate organ motion. Since the target moves in every direction, we need to take into account motion in each direction. This study proposes methods to evaluate gated radiation therapy using gamma index analysis and to visualize adequate gating window sizes according to motion ranges. The moving phantom was fabricated to simulate motion in the craniocaudal direction. This phantom consisted of a moving platform, the I'm MatriXX, and solid water phantoms. A 6 MV photon filed with a field size of $4{\times}4cm^2$ was delivered to the phantom using the gating system, while the phantom moved in the 1-, 2-, 3-, 4-, and 5-cm motion ranges. The gating windows were set at 40~60%, 30~40%, and 0~90%, respectively. The I'm MatriXX acquired the dose distributions for each scenario and the dose distributions were compared with a $4{\times}4cm^2$ static filed. The tolerance of the gamma index was set at 3%/3 mm. The greater the gating window, the lower the pass rate, and the greater the motion range, the lower the pass rate in this study. In case treatment without gated radiation therapy for the target with motion of 2 cm, the pass rate was less than 96%. But it was greater than 99% when gated radiation therapy was used. However gated radiation therapy was used for the target with motion greater than 4 cm, the pass rate could not be greater than 97% when gating window was set as 30~70%. But when the gating window set as 40~60%, the pass rate was greater than 99%.

Invivo Dosimetry for Mammography with and without Lead Apron Using the Glass Dosimeters

유수정,임상욱,마선영,서선열,김영재,강영남,금기창,조삼주,Yu, Su-Jeong,Lim, Sangwook,Ma, Sun Young,Seo, Sun-Youl,Kim, Young-Jae,Kang, Young-Nam,Keum, Ki Chang,Cho, Samju Korean Society of Medical Physics 2015 의학물리 Vol.26 No.2

본 연구는 유방촬영술을 시행할 때 유방인접조직의 생체내선량 측정을 통해 방호복 착용의 유용성을 평가하고자 한다. 이를 위해 유방검진을 받는 일반 여성 중 연구의 목적과 방법을 정확히 이해하고 동의한 환자 30명을 대상으로 유방촬영시 유리선량계를 이용하여 측정을 실시 하였다. 유리선량계의 교정값을 구하기 위하여 팬텀(ACR phantom)을 이용하여 촬영 변수중 각각 관전압과 관전류의 중간값(27 kVp, 120 mAs)고정 시 mAs와 kVp를 변화시켜 장치에서 계산된 선량을 얻어 유리선량계 소자의 교정값을 구하였다. 측정 그룹은 방호복을 착용하지 않는 A 그룹과 착용하지 않은 B 그룹으로 나누었다. 생체내 선량측정 특성상 동일한 환자를 대상으로 반복 촬영을 할 수 없음으로 A 그룹은 좌 우 유방촬영에 따라 인접 정상조직의 선량이 차이가 없을 보고자 하였다. B 그룹은 한쪽 유방은 방호복으로 차폐를 하고 다른 쪽 유방은 방호복으로 차폐를 하지 않음으로 그 차이를 보고자 하였다. 인접 정상조직 측정에는 갑상선, 검사반대측 유방, 하복부로 각각의 부위에 유리선량계를 위치시켜 측정하였다. 실험 결과 유방촬영 시 입사표면선량은 A그룹의 경우, 왼쪽유방 상하방향 검사 시 갑상선은 0.0692 mGy, 오른쪽 유방은 0.6790 mGy, 하복부의 선량은 0.0122 mGy로 나타났고, 오른쪽 상하방향 검사 시에는 각각 0.0607 mGy, 0.4062 mGy 그리고 0.0166 mGy로 측정되었다. B그룹의 입사표면선량은 왼쪽유방 상하방향 검사 시 갑상선, 오른쪽 유방, 하복부의 선량이 각각 0.0922 mGy, 0.8575 mGy, 0.0150 mGy로 나타났다. 방호복을 착용한 오른쪽 상하방향 검사는 갑상선이 0.0158 mGy, 왼쪽유방은 0.0286 mGy, 하복부가 0.0173 mGy의 선량을 보여 갑상선과 유방의 선량이 대폭 감소되었고 통계적으로 유의하였다(p<0.05). 모니터의 유선선량을 관찰해 보면 A, B그룹 모두 권고값인 3 mGy 이하의 선량값을 보였다. 본 연구 결과 유방촬영시 환자의 결정장기가 받는 표면선량은 모두 기준치 이하의 선량을 보였으나 방호복 착용에 따른 선량 저감 효과를 볼 수 있어 방호복의 유용성을 확인할 수 있었다. The purpose of this study is to see the usefulness of lead apron for critical organs near the breast under examining. For clinical experiment, 30 female volunteers who agreed to their participation in the experiments, were chosen and divided into two groups, 15 in group A and 15 in group B respectively. group A is to see whether each side of breast under mammography affects to other side glandular on the critical organs is same, because it is not allowed to scan the both breast for same person or to scan repeatedly. Group B is to see the effectiveness of lead apron during the mammography of right breast. Glass dosimeters were placed on the thyroid, the contralateral breast, and lower abdomen where near the breast during examining. The average glandular doses on the surface in mammography of the thyroid gland, the contralateral breast, the lower abdomen were 0.0692 mGy, 0.6790 mGy, and 0.0122 mGy, respectively, which was an extremely low level of glandular dose. In group B, as to the thyroid gland, average dose was decreased from 0.0922 mGy to 0.0158 mGy. The average dose of contralateral breast was decreased from 0.8575 mGy to 0.0286 mGy. The average doses of lower abdomen was decrease 0.0150 mGy to 0.0173 mGy. As to the lower abdomen, dose decreased from 0.0150 mGy before the use of an apron down to 0.0173 mGy after the use. As p-value was under 0.05, statistically significant difference was observed between the two groups. Wearing an apron can have the protective effects on the thyroid gland up to 20 times lower than not wearing one. Besides, it is also necessary to protect the other breast during the examination by wearing one.

온-보드 영상장치를 이용한 총체적 셋업의 정확성 분석

마선영,임상욱,강수만,정태식,Ma, Sun-Young,Lim, Sang-Wook,Kang, Soo-Man,Jeung, Tae-Sig Korean Society of Medical Physics 2011 의학물리 Vol.22 No.2

본 연구에서는 방사선사를 포함한 레이저, 갠트리 및 온-보드 영상장치의 총체적 셋업의 정확성을 평가하고자 하였다. 경험이 많은 방사선사에게 매일 아침 마커블록을 카우치의 Lock bar 시스템에 고정하고 마커블록을 레이저 중심에 맞추도록 하였다. 71일간 마커블록을 2D/2D 정합으로 위치를 보정하기 위하여 $0^{\circ}$ and $270^{\circ}$ 각도에서 한 쌍의 kV 영상을 획득하였다. 정합이 되었을 때 원격으로 카우치를 조정하여 셋업에러를 보정하고 보정 값은 저장하였다. 상하방향(vertical)과 앞뒤방향(longitudinal) 평균오차를 분석한 결과 상하방향은 0.65, 앞뒤방향은 0.66으로 나타났으며 반면에 좌우방향(lateral)은 0.01으로 나타났다. 상하방향과 앞뒤방향의 p 값은 모두 0.00으로 통계적으로 유의하게 나타났으며, 좌우방향에서는 p 값이 0.829로 나타나 계통오차를 발견하기 어려웠다. 총체적 셋업평가방법은 일간으로 시행하기에 유용하고 편리하였다. 그러나 계통오차를 줄이기 위해서 여전히 레이저와 OBI의 일간 점검은 필요하다. We evaluated the overall setup accuracy for the On-Board Imager (OBI, Varian Medical Systems Inc., Palo Alto, CA, USA), with attention to the laser, the gantry, and operator performance. We let experienced technicians place the marker block on the couch using a lock bar system, with alignment to the isocenter of the laser, every morning. A pair of radiographic images of the marker block was acquired at $0^{\circ}$ and $270^{\circ}$ angles to the kV arm to correct the position using a 2D/2D matching technique. Once the desired match was achieved, the couch was moved remotely to correct the setup error and the parameters were saved. The average for the vertical and the longitudinal displacements were 0.65 mm and 0.66 mm, and 0.01 mm for the lateral displacement. The average for the vertical and longitudinal displacements were statistically significant at the 0.05 level (p value=0.000 for both), while the p value for the lateral direction was 0.829. These results show that the tendencies to displacement in vertical and longitudinal directions occur through systematic error, while systematic error was not found in the lateral displacement. This daily overall evaluation is practical and easy to find the systematic and random errors in the setup system; however, a daily QA for laser and OBI alignment is still needed to minimize the systematic error in aligning patients.

Qualitative Evaluation of 2D Dosimetry System for Helical Tomotherapy

마선영,정태식,심장보,임상욱,Ma, Sun Young,Jeung, Tae Sig,Shim, Jang Bo,Lim, Sangwook Korean Society of Medical Physics 2014 의학물리 Vol.25 No.4

본 연구의 목적은 새로 개발된 2차원 토모테라피 선량측정 시스템의 가능성을 알아보는 것이다. 방사선이 조사되면 가시광성을 내보내는 인광판을 원통형 물팬텀에 삽입하였다. 치료계획장치에서 원 모양, C자 모양, 다중표적 3종류의 가상의 표적을 만들고 각 표적에 10 Gy의 방사선을 전달하도록 하였다. 원통형 팬텀을 토모테라피 치료테이블위에 올려놓고 치료계획대로 방사선을 조사하였다. CCD카메라로 쵤영된 모든 프레임은 누적되었고 각 픽셀은 선량으로 변환되었다. 인광판으로부터 나온 영상은 치료계획장치에서 계산된 선량분포와 비교하였다. 선량기울기(dose rate)와 픽셀값의 관계그래프는 선량기울기 900 MU/min 까지 포화(saturated)되지 않았다. 인광판의 선형성 보정이 개선된다면 인광판과 CCD카메라를 이용한 토모테라피의 2차원 선량측정이 유용할 것으로 기대한다. The purpose of this study is to see the feasibility of the newly developed 2D dosimetry system using phosphor screen for helical tomotherapy. The cylindrical water phantom was fabricated with phosphor screen to emit the visible light during irradiation. There are three types of virtual target, one is one spot target, another is C-shaped target, and the other is multiple targets. Each target was planned to be treated at 10 Gy by treatment planning system (TPS) of tomotherapy. The cylindrical phantom was placed on the tomotherapy table and irradiated as calculations of the TPS. Every frame which acquired by CCD camera was integrated and the doses were calculated in pixel by pixel. The dose distributions from the fluorescent images were compared with the calculated dose distribution from the TPS. The discrepancies were evaluated as gamma index for each treatment. The curve for dose rate versus pixel value was not saturated until 900 MU/min. The 2D dosimetry using the phosphor screen and the CCD camera is respected to be useful to verify the dose distribution of the tomotherapy if the linearity correction of the phosphor screen improved.

Outcomes after Reirradiation for Brain Metastases

유제상,최지훈,마선영,정태식,Yu, Jesang,Choi, Ji Hoon,Ma, Sun Young,Jeung, Taesig Korean Society of Medical Physics 2015 의학물리 Vol.26 No.3

방사선 재치료를 받은 뇌전이 환자를 대상으로 치료결과와 결과에 영향을 미치는 인자를 알아보고자 하였다. 2008년 6월부터 2012년 12월까지 완화목적의 뇌 방사선치료를 받은후 방사선 재치료를 받은 23명의 환자의 결과를 분석하였다. 첫 번째 전뇌 방사선치료 선량의 중앙값은 30 Gy (23.4~30 Gy) 이었다. 삼차원입체치료의 선량은 하루에 3 Gy로 총 30 Gy를 분할조사하였다. 정위적 방사선수술의 선량은 16 Gy를 1회 조사하였다. 방사선 재치료에서 전뇌 방사선치료, 삼차원 입체조형 치료의 중앙값은 각각 27.5 Gy와 30 Gy 이었다. 정위적 방사선수술의 재치료 선량은 16 Gy를 1회 조사하였다. 완화목적의 뇌 방사선치료 이후 뇌전이로 인한 증상 악화를 동반하고 영상학적으로 병변 진행이 확인되는 환자에서 방사선 재치료를 시행하였다. 경과 관찰기간의 중앙값은 25개월 이었다. 증상 관해율은 47.8%였고, 증상 완화의 효과 비율은 증상 유지 환자를 포함하여 82.6% 이었다. 재치료후 생존기간의 중앙값은 3.2개월이었다. 방사선 재치료 이후의 중앙값은 60으로 재치료 이전의 KPS 중앙값 30에 비해 향상되었다. 뇌전이 환자에서 방사선 재치료의 증상 완화 효과는 치료이전 KPS값이 60이상(: ECOG 0~2)의 전신수행상태가 좋은 환자에서 적합한 것으로 결과를 나타내었다. We retrospectively analyzed the outcomes in patients who underwent reirradiation for brain metastasis. Twenty-three patients with brain metastases who were initially treated with palliative brain radiotherapy and were retreated with a second course of brain RT between June 2008 and December 2012. WBRT, 3DCRT and SRS were used for brain metastasis. The median dose of the first course of WBRT was 30 Gy (range, 23.4~30 Gy). The dose of the first course 3DCRT for lesion was 30 Gy in 3 Gy per fraction. The median dose of the first course of SRS was 16 Gy in 1 fraction (range, 12~24 Gy). The median dose of the second course of WBRT was 27.5 (range, 12~30 Gy). The median dose of the second course of 3DCRT for lesion was 30 Gy (range, 25~30 Gy). The dose of the second course of SRS was 16 Gy in 1 fraction. The second course of WBRT was administered on radiographic disease progression with symptom in all patients. With median follow-up of 25 months, overall symptom resolution rates were 47.8%. Rate of palliative efficacy was 82.6% including stable disease. The median survival time after initiation of reirradiation was 3.2 months. Median value of KPS prior to reirradiation was 30. Median value of KPS after reirradiation was 60. Reirradiation of brain metastasis maybe feasible and effective in select patients with a good performance status $KPS{\geq}60$ (: ECOG 0~2) prior to reirradiation.

비인두암의 방사선치료 결과

신병철(Byung Chul Shin),마선영(Sun Young Ma),문창우(Chang Woo Moon),염하용(Ha Yong Yum),정태식(Tae Sig Jeung),유명진(Myung Jin Yoo) 대한방사선종양학회 1995 Radiation Oncology Journal Vol.13 No.3

Purpose : The aim of this study was to assess the effectiveness, survival rate and complication of radiation therapy in nasopharyngeal cancer. Materials and Methods : From January 1980 to May 1989. Fifty patients who had nasoparyngeal carcinoma treated with curative radiation therapy at Kosin Medical Center were retrospectively studied. Thirty seven patients (74%) were treated with radiation therapy alone(Group Ⅰ) and 13 patients (26%) treated with combination chemotherapy and radiation(Group Ⅱ). Age distribution was 16-75 years (median: 45.8 years). In histologic type, squamous cell carcinoma was in 30 patients(60%), undifferentiated carcinoma in 17 patients(34%), and lymphoepithelioma in 3 patients(6%). According to AJCC staging system, 4 patients(8%) were in T₁, 13 patients (26%) in T₂. 20 patients (40%) in T₃, 13 patients(26%) in T₄ and 7 patients (14%) in T?, 6 patients (12%) in N₁, 23 patients (46%) in N₂, 13 patients (28%) in N₃. Total radiation dose ranges were 5250-9200cGy(median: 7355cGy) in Group Ⅰ and 5360-8400cGy(median:6758Cgy) in Group Ⅱ. Radiotherapy on 4-6MV linear accelerator and/or 6-12MeV electron in boost radiation was given with conventional technique to 26 patients (52%), with hyperfractionation(115-120cGy/fr., 2times/day) to 16 patients (32%), with accelerated fractionation(160cGy/fr., 2times/day) to 8 patients(16%). In chemotherapy. 5 FU 1000mg daily for 5 consecutive days, pepleomycin 10mg on days 1 and 3, and cisplatin 100mg on day 1 were administered with 3weeks interval, total 1 to 3 cycles(average 1.8 cycles) prior to radiation therapy. Follow up duration was 6-140 months(mean: 58 months). Statistics was calculated with with Chi-square and Fisher's exact test. Results : complete local control rates in Group Ⅰ and Ⅱ were 75.7%, 69.2%, Overall 5 year survival rates in Group Ⅰ and Ⅱ were 56.8%, 30.8%. Five year survival rates by histologic type in Group Ⅰand Ⅱ were 52.2%, 14.3% in squamous cell carcinoma and 54.5%, 50% in undifferentiated carcinoma. Survival rates in Group Ⅰ were superior to those of Group Ⅱ though there were not statistically significant. In both group, survival rates seem to be increased according to increasing total dose of radiation up to 7500cGy, but not increased beyond it. There were not statistically significant differences in survival rates by age, stage, and radiation techniques in both group. Twenty four patients(48%) expericenced treatment failures. Complications were found in 12 patients(24%). The most common one was osteomyelitis(4 patients, 33.3%) involving mandible (3 patients) and maxilla(1 patient). Conclusion : Chemotherapy in combination with radiotherapy was found to be not effective to nasopharyngeal cancer and the survival rate was also inferior to that of radiation alone group though it was statistically not significant due to small population in chemotherapy combined group.

호흡연동방사선치료시 폐암과 간암환자의 병소 움직임 크기에 따른 선량분포 차이 분석

김영국,임상욱,최지훈,마선영,정태식,노태익,Kim, Youngkuk,Lim, Sangwook,Choi, Ji Hoon,Ma, Sun Young,Jeung, Tae Sig,Ro, Tae Ik 한국의학물리학회 2014 의학물리 Vol.25 No.4

호흡연동방사선치료(respiratory-gated radiation therapy)법을 적용한 세기조절방사선치료(intensity-modulated radiation therapy, IMRT) 시 환자의 호흡에 의한 장기 움직임 크기에 따른 계산된 선량분포와 측정된 선량분포의 차이를 분석하고자 한다. 치료를 완료한 폐암과 간암 환자 4명을 선택하였다. 한 환자당 5개의 조사면 총 20개의 조사면을 갠트리 각도를 모두 $0^{\circ}$로 변경하여 치료계획시스템(Eclipse Ver. 8.1, Varian Medical Systems, Inc., USA)으로 다시 계산하였다. 치료계획과 동일한 조건으로 각 IMRT 조사면을 2차원 이온전리함배열(MatriXX, IBA Dosimetry, Germany)을 자체 제작한 호흡모 플랫폼(respiratory simulating platform)위에 놓고 0, 1.0, 2.0, 및 3.0 cm 씩 호흡 움직임을 모사하여 일반적으로 치료에 사용되는 연동창 범위인 30~70% 위상을 선택하여 호흡연동방사선치료법으로 조사하여 선량분포를 측하였다. 계산된 선량분포와 측정된 선량분포의 2차원적 비교를 위해 소프트웨어(Omni-pro I'mRT, IBA Dosimetry, Germany)를 이용하여 3 mm/3%의 기준으로 감마 지표(gamma index)로 비교하였다. 움직임이 없을 때 감마 지표의 합격률이 평균 98.63% 였으며, 움직임을 1.0, 2.0, 3.0 cm으로 모사할 경우 합격률이 각각 평균 98.59%, 97.82%, 95.84%로 낮아졌다. 따라서 실제 환자에 대해 호흡연동방사선치료법을 적용한 세기조절방사선치료 시 병소의 움직임이 2 cm가 넘을 경우 ITV (internal target volume) 여유분을 크게 설정하거나 연동창을 좁게 선택하여야한다. To see the discrepancies between the calculated and the delivered dose distribution of IMRT fields for respiratory-induced moving target according to the motion ranges. Four IMRT plans in which there are five fields, for lung and liver patients were selected. The gantry angles were set to $0^{\circ}$ for every field and recalculated using TPS (Eclipse Ver 8.1, Varian Medical Systems, Inc., USA). The ion-chamber array detector (MatriXX, IBA Dosimetry, Germany) was placed on the respiratory simulating platform and made it to move with ranges of 1, 2, and 3 cm, respectively. The IMRT fields were delivered to the detector with 30~70% gating windows. The comparison was performed by gamma index with tolerance of 3 mm and 3%. The average pass rate was 98.63% when there's no motion. When 1.0, 2.0, 3.0 cm motion ranges were simulated, the average pass rate were 98.59%, 97.82%, and 95.84%, respectively. Therefore, ITV margin should be increased or gating windows should be decreased for targets with large motion ranges.